Oculocutaneous albinism type 1 Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

1 event

Dec 2025Safety and Efficacy of a Single Suprachoroidal Injection of JWK010 Gene Therapy in Subjects With Oculocutaneous Albinism Type 1 (OCA1)

West China Hospital — EARLY_PHASE1

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Oculocutaneous albinism type 1.
Check the disease page for updates →

Clinical Trial Landscape

1 active trial

1EARLY_PHASE1

1Total recruiting

Search clinical trials for Oculocutaneous albinism type 1 →

Recent News & Research

No recent news articles indexed yet for Oculocutaneous albinism type 1.
Search PubMed for Oculocutaneous albinism type 1 →

Browse all Oculocutaneous albinism type 1 news →

Specialist Network

Top 4 by expertise

Jeffrey Weber

University of Southern California

Score 274 trials62 pubs

BioNTech Responsible Person

BioNTech SE

Score 1318 trials

Fang Lu

Department of Ophthalmology, West China Hospital, Sichuan University

Score 92 trials

Jedd Wolchok, MD

Memorial Sloan Kettering Cancer Center

📍 NEW YORK, NY

Score 01 trial

View all Oculocutaneous albinism type 1 specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰